These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 12055125)

  • 1. Endothelial AT(2)-receptors: chicken or egg?
    Vanhoutte PM
    Br J Pharmacol; 2002 Jun; 136(4):481-3. PubMed ID: 12055125
    [No Abstract]   [Full Text] [Related]  

  • 2. AT(2) receptor-dependent vasodilation is mediated by activation of vascular kinin generation under flow conditions.
    Katada J; Majima M
    Br J Pharmacol; 2002 Jun; 136(4):484-91. PubMed ID: 12055126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation.
    Tsutsumi Y; Matsubara H; Masaki H; Kurihara H; Murasawa S; Takai S; Miyazaki M; Nozawa Y; Ozono R; Nakagawa K; Miwa T; Kawada N; Mori Y; Shibasaki Y; Tanaka Y; Fujiyama S; Koyama Y; Fujiyama A; Takahashi H; Iwasaka T
    J Clin Invest; 1999 Oct; 104(7):925-35. PubMed ID: 10510333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Farnesoid X receptor regulates vasoreactivity via Angiotensin II type 2 receptor and the kallikrein-kinin system in vascular endothelial cells.
    Zhang R; Ran H; Peng L; Zhang Y; Shen W; Sun T; Cao F; Chen Y
    Clin Exp Pharmacol Physiol; 2016 Mar; 43(3):327-34. PubMed ID: 26710942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of prolylcarboxypeptidase in angiotensin II type 2 receptor-mediated bradykinin release in mouse coronary artery endothelial cells.
    Zhu L; Carretero OA; Liao TD; Harding P; Li H; Sumners C; Yang XP
    Hypertension; 2010 Sep; 56(3):384-90. PubMed ID: 20606103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Kinins: their nature and their potential role in the cardiovascular effects of angiotensin-converting enzyme inhibitors].
    Adam A; Blais C; Loute G
    Nephrologie; 2000; 21(4):163-72. PubMed ID: 10976431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of bradykinin, AT2 and angiotensin 1-7 receptors in the EDRF-dependent vasodilator effect of angiotensin II on the isolated mesenteric vascular bed of the rat.
    Soares de Moura R; Resende AC; Emiliano AF; Tano T; Mendes-Ribeiro AC; Correia ML; de Carvalho LC
    Br J Pharmacol; 2004 Mar; 141(5):860-6. PubMed ID: 14757704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial and myocyte apoptosis--role of angiotensin II.
    Hamet P; deBlois D
    Can J Cardiol; 2001 May; 17 Suppl A():26A-8A. PubMed ID: 11381292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bradykinin formation. Plasma and tissue pathways and cellular interactions.
    Kaplan AP; Joseph K; Shibayama Y; Nakazawa Y; Ghebrehiwet B; Reddigari S; Silverberg M
    Clin Rev Allergy Immunol; 1998; 16(4):403-29. PubMed ID: 9926288
    [No Abstract]   [Full Text] [Related]  

  • 10. Myeloperoxidase interacts with endothelial cell-surface cytokeratin 1 and modulates bradykinin production by the plasma Kallikrein-Kinin system.
    Astern JM; Pendergraft WF; Falk RJ; Jennette JC; Schmaier AH; Mahdi F; Preston GA
    Am J Pathol; 2007 Jul; 171(1):349-60. PubMed ID: 17591979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac angiotensin II type 2 receptor activates the kinin/NO system and inhibits fibrosis.
    Kurisu S; Ozono R; Oshima T; Kambe M; Ishida T; Sugino H; Matsuura H; Chayama K; Teranishi Y; Iba O; Amano K; Matsubara H
    Hypertension; 2003 Jan; 41(1):99-107. PubMed ID: 12511537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin II type 2 receptors in the kidney: evidence for endothelial-cell-mediated renal vasodilatation.
    Arima S; Ito S
    Nephrol Dial Transplant; 2000 Apr; 15(4):448-51. PubMed ID: 10727534
    [No Abstract]   [Full Text] [Related]  

  • 13. Potent antihypertrophic effect of the bradykinin B2 receptor system on the renal vasculature.
    Tsuchida S; Miyazaki Y; Matsusaka T; Hunley TE; Inagami T; Fogo A; Ichikawa I
    Kidney Int; 1999 Aug; 56(2):509-16. PubMed ID: 10432390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma kallikrein/kinin system: a revised hypothesis for its activation and its physiologic contributions.
    Schmaier AH
    Curr Opin Hematol; 2000 Sep; 7(5):261-5. PubMed ID: 10961574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutrophils engage the kallikrein-kinin system to open up the endothelial barrier in acute inflammation.
    Kenne E; Rasmuson J; Renné T; Vieira ML; Müller-Esterl W; Herwald H; Lindbom L
    FASEB J; 2019 Feb; 33(2):2599-2609. PubMed ID: 30281335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin IV receptor-mediated activation of lung endothelial NOS is associated with vasorelaxation.
    Patel JM; Martens JR; Li YD; Gelband CH; Raizada MK; Block ER
    Am J Physiol; 1998 Dec; 275(6):L1061-8. PubMed ID: 9843842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple interactions between the renin-angiotensin and the kallikrein-kinin systems: role of ACE inhibition and AT1 receptor blockade.
    Tschöpe C; Schultheiss HP; Walther T
    J Cardiovasc Pharmacol; 2002 Apr; 39(4):478-87. PubMed ID: 11904521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II type 2 receptor inhibits vascular endothelial growth factor-induced migration and in vitro tube formation of human endothelial cells.
    Benndorf R; Böger RH; Ergün S; Steenpass A; Wieland T
    Circ Res; 2003 Sep; 93(5):438-47. PubMed ID: 12881481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The renin-angiotensin and the kallikrein-kinin systems.
    Campbell DJ
    Int J Biochem Cell Biol; 2003 Jun; 35(6):784-91. PubMed ID: 12676165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin II and the endothelium: diverse signals and effects.
    Watanabe T; Barker TA; Berk BC
    Hypertension; 2005 Feb; 45(2):163-9. PubMed ID: 15630047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.